Results 51 to 60 of about 1,157 (167)
Severe hemolytic disease of the fetus and newborn (HDFN) requiring intrauterine transfusions (IUTs) may cause iron accumulation, resulting in liver damage, which may lead to cholestasis and coagulation disorders.
Natalia Mazanowska +5 more
core +1 more source
AABB survey on directed blood donation practices
Abstract Background Standardized guidance regarding the processes for collecting directed blood donations (DBD) is lacking, leading to variable practices. This study assessed laboratory, clinical, and charging practices for DBD collection in the United States and Canada. Study Design and Methods An electronic survey was distributed to United States and
Nabiha H. Saifee +6 more
wiley +1 more source
Abstract Background Maternal red cell alloimmunization can cause hemolytic disease of the fetus and newborn (HDFN), yet prediction of disease severity remains limited. Biobanks that link pregnancy biospecimens with clinical and laboratory data could accelerate translational research; however, the landscape of relevant obstetric biobanks has not been ...
Orlin Chowdhury +10 more
wiley +1 more source
Hemolytic disease of the fetus and newborn
Bakalářská práce se zabývá hemolytickým onemocněním plodu a novorozence. Práce je rozdělena na teoretickou a praktickou část. Teoretická část popisuje imunohematotologii, vybrané krevně skupinové systémy, bilirubin a druhy hyperbilirubinémií novorozence.
Strnádková, Adéla
core
Unexpected neonatal ABO discrepancy revealing ABO*cisAB.05 during routine cord blood testing
Abstract Background An apparent AB blood group in a neonate born to a group O mother can raise diagnostic, transfusion, and parentage‐sensitive concerns. CisAB alleles are rare ABO variants in which a single inherited allele encodes glycosyltransferase activity producing both A and B antigens.
Ali Ghais +8 more
wiley +1 more source
Neonatal sepsis in alloimmune hemolytic disease of the fetus and newborn: a retrospective cohort study of 260 neonates [PDF]
Background: Among neonates with hemolytic disease of the fetus and newborn (HDFN), we aimed to describe the frequency of central-line use, indications for insertion, and incidence of confirmed and suspected sepsis, including antibiotic treatment over a ...
Ree, I.M.C. +13 more
core +1 more source
BACKGROUND: Clinical manifestations of hemolytic disease of the fetus and newborn include anemia, hyperbilirubinemia, hydrops fetalis, kernicterus, and fetal or neonatal demise.
Alexis A. Krumme, ScD +6 more
doaj +1 more source
Abstract Background In patients with variant RhD phenotypes, serologic reactions for partial RHD genotypes are indistinguishable from other variants. Study Design and Methods In two US transfusion services, patients were typed for RhD by automated microplate RhD typing (Werfen, Norcross, GA) using two directly agglutinating IgM anti‐D reagents, MS201 ...
Vidyadhari Karne +4 more
wiley +1 more source
Anti-G antibody in alloimmunized pregnant women: Report of two cases
Anti-G has been reported as a possible cause of hemolytic disease of the fetus and newborn (HDFN), either independently or in association with anti-D, anti-C or both.
Raj Nath Makroo +5 more
doaj +1 more source
Abstract Background As prehospital transfusion becomes more common in the United States (US), cases of hemolytic disease of the fetus and newborn (HDFN) might increase. This study forecasted the number of HDFN cases in 2029 resulting from RhD‐positive prehospital transfusions. Study Design and Methods A regression was performed on the number of females
Adnan S. Syed +6 more
wiley +1 more source

